This two-year investigation was produced in collaboration with students at the Craig Newmark Graduate School of Journalism at ...

The FTC is broadening its campaign to curb alleged patent abuses by the pharma industry, disputing over 300 patent listings ...

Patients desperate for relief from debilitating diseases were asked to participate in research study, prompting a review by the Food and Drug Administration. In other news, a treatment to restore ...

Multi-cancer-screening tools—or “ cancer-finding supertests ,” as Galleri has been called— aren’t yet endorsed by the U.S.

A prostate cancer biomarker test that utilizes genes indicating high-grade prostate cancer appears highly accurate.

New urine-based test looks at 18 genes and was specifically developed to pick out those cancers that need immediate treatment ...

A study in JAMA Oncology reveals that MyProstateScore 2.0, a new urine test analyzing 18 genes, surpasses PSA in detecting ...

“Four of 10 men who would have a negative biopsy will have a low risk MPS2 result and can confidently skip a biopsy," Wei ...

A urine test which looks at 18 genes linked to aggressive prostate cancer could help men with the slow-growing form of the ...

A new urine test that measures 18 genes associated with prostate cancer provides higher accuracy for detecting clinically ...

Prostate MRI integration in prostate cancer (PCa) screening pathways was associated with a reduced number of unnecessary biopsies and overdiagnosis of insignificant PCa, according to one study.

Researchers have developed a new urine-based test that addresses a major problem in prostate cancer: how to separate the slow-growing form of the disease unlikely to cause harm from more aggressive ...